Disc Medicine (IRON) Net Income towards Common Stockholders (2020 - 2026)

Disc Medicine (IRON) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$63.6 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 87.11% year-over-year to -$63.6 million in Q1 2026; TTM through Mar 2026 was -$196.8 million, a 68.81% decrease from a year earlier, with the FY2025 full-year figure at -$167.3 million, down 53.02% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$63.6 million, down from -$15.7 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for IRON reached as high as -$9.6 million in Q2 2022 and fell as low as -$63.6 million in Q1 2026.
• Historically, Net Income towards Common Stockholders has averaged -$27.3 million across 5 years, with a median of -$23.6 million in 2023.
• On a YoY basis, Net Income towards Common Stockholders climbed as much as 48.27% in 2022 and fell as far as 155.96% in 2022.
• Year by year, Net Income towards Common Stockholders stood at -$11.2 million in 2022, then plunged by 109.7% to -$23.6 million in 2023, then fell by 25.69% to -$29.6 million in 2024, then jumped by 47.07% to -$15.7 million in 2025, then slumped by 305.13% to -$63.6 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$63.6 million in Q1 2026, -$15.7 million in Q4 2025, and -$62.3 million in Q3 2025.